We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
Cap. Flow
+$7.6B
Cap. Flow %
5.51%
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351

Sector Composition

Rank Sector Weight
1 Healthcare 12.22%
2 Technology 11.9%
3 Financials 9.98%
4 Consumer Discretionary 7.32%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOSS icon
3226
Gossamer Bio
GOSS
$82.9M
$750K ﹤0.01%
48,005
+31,448
+190% +$633K
ETN icon
3227
PUT
Eaton
ETN
$161B
$748K ﹤0.01%
+7,900
New +$701K
FOSL icon
3228
PUT
Fossil Group
FOSL
$293M
$748K ﹤0.01%
94,900
+33,800
+55% +$312K
SEB icon
3229
Seaboard Corp
SEB
$4.23B
$748K ﹤0.01%
176
+33
+23% +$138K
AERI
3230
DELISTED
Aerie Pharmaceuticals
AERI
$747K ﹤0.01%
30,915
-166,126
-84% -$3.44M
REX icon
3231
REX American Resources
REX
$1.42B
$744K ﹤0.01%
54,516
-3,828
-7% -$53K
CCRD
3232
DELISTED
CoreCard
CCRD
$742K ﹤0.01%
18,579
-1,251
-6% -$54.3K
SNEX icon
3233
StoneX
SNEX
$9.26B
$742K ﹤0.01%
76,996
+3,104
+4% +$25.7K
GTHX
3234
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$742K ﹤0.01%
28,057
+3,108
+12% +$72.7K
POLY
3235
DELISTED
Plantronics, Inc.
POLY
$741K ﹤0.01%
27,127
-10,100
-27% -$304K
AAMI
3236
Acadian Asset Management
AAMI
$3.08B
$740K ﹤0.01%
72,455
+1,473
+2% +$14.4K
AMPH icon
3237
Amphastar Pharmaceuticals
AMPH
$879M
$739K ﹤0.01%
38,342
-636
-2% -$12.2K
HROW icon
3238
Harrow
HROW
$1.45B
$738K ﹤0.01%
+94,803
New +$549K
KBAL
3239
DELISTED
Kimball International
KBAL
$738K ﹤0.01%
35,743
-6,510
-15% -$134K
TFIN icon
3240
Triumph Financial Inc
TFIN
$1.81B
$737K ﹤0.01%
19,396
+4,128
+27% +$143K
BORR
3241
Borr Drilling
BORR
$1.24B
$735K ﹤0.01%
40,630
-24,116
-37% -$321K
SRE.PRB
3242
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
$733K ﹤0.01%
6,155
+3,155
+105% +$370K
BJRI icon
3243
BJ's Restaurants
BJRI
$1.42B
$732K ﹤0.01%
19,306
-75,798
-80% -$2.91M
DNLI icon
3244
Denali Therapeutics
DNLI
$3.65B
$732K ﹤0.01%
42,004
-5,894
-12% -$98.1K
RTLR
3245
DELISTED
Rattler Midstream LP Common Units
RTLR
$729K ﹤0.01%
40,967
-1,326
-3% -$21.1K
TELL
3246
CALL
DELISTED
Tellurian Inc.
TELL
$728K ﹤0.01%
100,000
VOT icon
3247
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
$727K ﹤0.01%
4,578
-15,759
-77% -$2.4M
PBI icon
3248
PUT
Pitney Bowes
PBI
$2.4B
$725K ﹤0.01%
180,000
HAFC icon
3249
Hanmi Financial
HAFC
$945M
$723K ﹤0.01%
36,146
+12,890
+55% +$249K
NNA
3250
DELISTED
Navios Maritime Acquisition Corporation
NNA
$719K ﹤0.01%
+84,588
New +$672K

Similar funds

Credit Suisse's Q4 2019 Portfolio in Review

As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.

  • Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
  • Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
  • Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
  • Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
  • Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
  • Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.

Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.